Free Trial

Dianthus Therapeutics (DNTH) SEC Filings & 10K Form

Dianthus Therapeutics logo
$18.12 -0.63 (-3.36%)
Closing price 04:00 PM Eastern
Extended Trading
$18.12 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Dianthus Therapeutics SEC Filings

DateFilerForm TypeView
05/22/2025
3:39 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Read Simon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2025
3:40 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:41 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Lawton Alison Frances (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:41 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
McGeorge Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:42 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
3:43 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
1:17 PM
BlackRock, Inc. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SCHEDULE 13G/A
04/17/2025
3:10 PM
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
04/10/2025
3:31 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form DEF 14A
04/10/2025
3:33 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form DEFA14A
04/10/2025
3:36 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form ARS
03/19/2025
8:30 PM
Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SCHEDULE 13D/A
03/05/2025
6:16 AM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:32 PM
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
6:54 AM
BCLS Fund III Investments, LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
4:42 PM
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Octagon Capital Advisors LP (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:21 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:23 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:27 PM
CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
8:19 PM
Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13D/A
11/22/2024
3:41 PM
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
11/14/2024
4:47 PM
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:48 PM
5AM Partners VII, LLC (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G/A
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G
10/21/2024
3:19 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form RW
10/09/2024
11:15 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
10/09/2024
11:15 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
10/01/2024
7:00 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:31 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/01/2024
3:36 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/18/2024
4:38 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
4:32 PM
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
7:45 PM
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Viridian, LLC (Filed by)
Form SC 13D/A
08/08/2024
3:26 PM
Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DNTH) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners